Osiris Therapeutics Announces Appointment of Alberto Avendano, M.D. as Chief Medical Officer
October 06, 2016 17:00 ET
|
Osiris Therapeutics, Inc.
COLUMBIA, Md., Oct. 06, 2016 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ:OSIR) today announced that it has appointed R. Alberto Avendano, M.D., as the Company’s Chief Medical Officer. ...
Osiris Therapeutics to Present at 2016 Cell & Gene Meeting on the Mesa
October 04, 2016 16:30 ET
|
Osiris Therapeutics, Inc.
COLUMBIA, Md., Oct. 04, 2016 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ:OSIR) announced today that Alla Danilkovitch, Ph.D., Chief Scientific Officer, will present at the annual...
Osiris Provides Update Regarding NASDAQ Listing Status
September 16, 2016 17:15 ET
|
Osiris Therapeutics, Inc.
COLUMBIA, Md., Sept. 16, 2016 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ:OSIR) (the “Company”) provided today an update concerning the status of its compliance with the Listing Rules of...
Osiris Provides Update Regarding NASDAQ Listing Matters
August 17, 2016 17:00 ET
|
Osiris Therapeutics, Inc.
COLUMBIA, Md., Aug. 17, 2016 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ:OSIR) (the “Company”) today provided an update regarding the status of its compliance with the Listing Rules of...
Grafix® Manuscript Reporting Positive Outcomes of Multicenter Chronic Complex Wounds with Exposed Tendon and Bone Clinical Trial is Available Electronically in Peer-Reviewed Journal
August 04, 2016 16:33 ET
|
Osiris Therapeutics, Inc.
COLUMBIA, Md., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading cellular regenerative medicine company focused on developing and marketing products to treat...